SOX combined with sintilimab versus SOX alone in the perioperative management of locally advanced gastric cancer: a propensity score–matched analysis

OBJECTIVES: To evaluate the efficacy of SOX combined with a programmed cell death protein-1 (PD-1) inhibitor compared with SOX alone in the perioperative management of locally advanced gastric cancer and to explore biomarkers that may predict response to anti-PD-1 therapy. METHODS: Data of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xingmao, Fang, Jingquan, Huang, Ling, Chen, Hang, Chen, Han, Chai, Tengjiao, Ye, Zeyao, Chen, Hanguang, Xu, Qi, Du, Yian, Yu, Pengfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640399/
https://www.ncbi.nlm.nih.gov/pubmed/37768447
http://dx.doi.org/10.1007/s10120-023-01431-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640399/
https://www.ncbi.nlm.nih.gov/pubmed/37768447
http://dx.doi.org/10.1007/s10120-023-01431-z

Ejemplares similares